Market Overview:
The global scar treatment market is expected to grow at a CAGR of 5.8% from 2018 to 2030. The growth in the market can be attributed to factors such as rising incidence of skin injuries, increasing awareness about available treatment options, and technological advancements in scar treatment products. Based on type, the global scar treatment market is segmented into creams, gels, scar sheets, and other products. The creams segment is expected to dominate the market during the forecast period owing to their easy availability and low cost. Based on application, the global Scar Treatment Market is segmented into hospitals and dermatology clinics.
Product Definition:
Scar treatment is the medical term for any interventions that are done to improve the appearance of a scar. This can include anything from topical treatments, such as silicone sheeting or gels, to surgical procedures, such as dermabrasion or laser therapy.
Creams:
Creams are topical medicines used for the treatment of scars. They are available in various forms such as gels, creams, and ointments. The active ingredients in these products include retinoids, alpha-hydroxy acids (AHA), and hydroxy acids that help reduce the appearance of scars by improving skin texture along with lightening discoloration caused due to sun exposure or any other reason.
Gels:
Gels are a group of medical devices used for the treatment of chronic wounds. They are biodegradable and non-toxic to the skin cells. The gels consist of water-based solutions that contain medication or drugs that help in healing and closing the wound faster than normal tissue can heal itself. Gels have been proven effective in treating moderate to severe acne scars, especially when combined with topical corticosteroids (a type of medicine).
Application Insights:
Based on the application, the market is segmented into hospitals, dermatology clinics and others. The hospitals segment dominated the overall industry in terms of revenue in 2017. This can be attributed to factors such as high patient admissions due to burns or trauma and increasing number of surgeries for scar treatment at hospitals. In addition, a rise in military personnel suffering from burn injuries is expected to drive demand over the forecast period.
The dermatology clinics segment is anticipated to witness significant growth over the forecast period owing to rising awareness about skin care among consumers coupled with an increase in demand for non-invasive procedures for treating scars resulting from burns or trauma wounds at low cost than conventional surgeries which are generally expensive treatments that require hospitalization along with costly procedures that may take several weeks before healing begins after injury has healed completely.
Regional Analysis:
North America dominated the global market in 2017. The region is expected to maintain its position during the forecast period due to increasing cases of burns and trauma injuries, rising awareness about cosmetic surgery, availability of skilled professionals and high disposable income of consumers.
Asia Pacific is anticipated to witness lucrative growth over the coming years owing to growing medical tourism in emerging countries such as India, China, Thailand & Australia. In addition, an increase in spending capacity among middle-class groups will boost demand for aesthetic products over the next eight years. ‘‘‘‘ ’ â‘‘ â“œœŸ¡ƒ©©©©¿Ð°°° ° ° °' ' '' '' '''''''''''''''' "'"' "'""" "# $%&()*+,-.
Growth Factors:
- Increasing prevalence of scars due to various reasons such as accidents, burns, and surgeries is expected to drive the growth of the scar treatment market.
- Rising demand for minimally invasive and non-invasive scar treatment procedures is anticipated to fuel the growth of this market in the near future.
- Growing awareness about available scar treatment options among people is projected to boost this market in the next few years.
- Technological advancements in scar treatment procedures are likely to create new opportunities for players operating in this market during the forecast period.
Scope Of The Report
Report Attributes
Report Details
Report Title
Scar Treatment Market Research Report
By Type
Creams, Gels, Scar Sheets, Other
By Application
Hospitals, Dermatology Clinics
By Companies
Perrigo Company, Smith & Nephew, Alliance Pharma, Rejûvaskin, HRA Pharma, Molnlycke Health Care, Sonoma Pharmaceuticals, Sientra, Pacific World Corporation, CCA Industries, Velius, Shanghai Shyndec Pharmaceutical, Merz Pharma GmbH, Bausch Health
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
179
Number of Tables & Figures
126
Customization Available
Yes, the report can be customized as per your need.
Global Scar Treatment Market Report Segments:
The global Scar Treatment market is segmented on the basis of:
Types
Creams, Gels, Scar Sheets, Other
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Hospitals, Dermatology Clinics
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Perrigo Company
- Smith & Nephew
- Alliance Pharma
- Rejûvaskin
- HRA Pharma
- Molnlycke Health Care
- Sonoma Pharmaceuticals
- Sientra
- Pacific World Corporation
- CCA Industries
- Velius
- Shanghai Shyndec Pharmaceutical
- Merz Pharma GmbH
- Bausch Health
Highlights of The Scar Treatment Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Creams
- Gels
- Scar Sheets
- Other
- By Application:
- Hospitals
- Dermatology Clinics
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Scar Treatment Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Scar treatment is the process of treating scars, including any physical or emotional trauma that may have resulted in a scar. Scar treatment can involve various methods, such as surgery, laser therapy, and massage.
Some of the major companies in the scar treatment market are Perrigo Company, Smith & Nephew, Alliance Pharma, Rej»vaskin, HRA Pharma, Molnlycke Health Care, Sonoma Pharmaceuticals, Sientra, Pacific World Corporation, CCA Industries, Velius, Shanghai Shyndec Pharmaceutical, Merz Pharma GmbH, Bausch Health.
The scar treatment market is expected to grow at a compound annual growth rate of 5.8%.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Scar Treatment Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 Scar Treatment Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 Scar Treatment Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the Scar Treatment Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global Scar Treatment Market Size & Forecast, 2020-2028
4.5.1 Scar Treatment Market Size and Y-o-Y Growth
4.5.2 Scar Treatment Market Absolute $ Opportunity
Chapter 5 Global Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Market Size Forecast by Type
5.2.1 Creams
5.2.2 Gels
5.2.3 Scar Sheets
5.2.4 Other
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Market Size Forecast by Applications
6.2.1 Hospitals
6.2.2 Dermatology Clinics
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global Scar Treatment Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Scar Treatment Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Analysis and Forecast
9.1 Introduction
9.2 North America Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Market Size Forecast by Type
9.6.1 Creams
9.6.2 Gels
9.6.3 Scar Sheets
9.6.4 Other
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Market Size Forecast by Applications
9.10.1 Hospitals
9.10.2 Dermatology Clinics
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Analysis and Forecast
10.1 Introduction
10.2 Europe Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Market Size Forecast by Type
10.6.1 Creams
10.6.2 Gels
10.6.3 Scar Sheets
10.6.4 Other
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Market Size Forecast by Applications
10.10.1 Hospitals
10.10.2 Dermatology Clinics
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Market Size Forecast by Type
11.6.1 Creams
11.6.2 Gels
11.6.3 Scar Sheets
11.6.4 Other
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Market Size Forecast by Applications
11.10.1 Hospitals
11.10.2 Dermatology Clinics
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Analysis and Forecast
12.1 Introduction
12.2 Latin America Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Market Size Forecast by Type
12.6.1 Creams
12.6.2 Gels
12.6.3 Scar Sheets
12.6.4 Other
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Market Size Forecast by Applications
12.10.1 Hospitals
12.10.2 Dermatology Clinics
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Market Size Forecast by Type
13.6.1 Creams
13.6.2 Gels
13.6.3 Scar Sheets
13.6.4 Other
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Market Size Forecast by Applications
13.10.1 Hospitals
13.10.2 Dermatology Clinics
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 Scar Treatment Market: Competitive Dashboard
14.2 Global Scar Treatment Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 Perrigo Company
14.3.2 Smith & Nephew
14.3.3 Alliance Pharma
14.3.4 Rejûvaskin
14.3.5 HRA Pharma
14.3.6 Molnlycke Health Care
14.3.7 Sonoma Pharmaceuticals
14.3.8 Sientra
14.3.9 Pacific World Corporation
14.3.10 CCA Industries
14.3.11 Velius
14.3.12 Shanghai Shyndec Pharmaceutical
14.3.13 Merz Pharma GmbH
14.3.14 Bausch Health
